Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 90 of the 92 references it cites were found in a registry or an index.

How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review

Open access
Hoch, Eva, Niemann, Dominik, von Keller, Rupert, Schneider, Miriam, Friemel, Chris M., Preuss, Ulrich W., Hasan, Alkomiet, Pogarell, Oliver · 2019 · European Archives of Psychiatry and Clinical Neuroscience

Abstract

We conducted a review of systematic reviews (SRs) and randomized-controlled trials (RCTs) to analyze efficacy and safety of cannabis-based medication in patients with mental disorders. Five data bases were systematically searched (2006-August 2018); 4 SRs (of 11 RCTs) and 14 RCTs (1629 participants) were included. Diagnoses were: dementia, cannabis and opioid dependence, psychoses/schizophrenia, general social anxiety, posttraumatic stress disorder, anorexia nervosa, attention-deficit hyperactivity disorder, and Tourette`s disorder. Outcome variables were too heterogeneous to conduct a meta-analysis. A narrative synthesis method was applied. The study quality was assessed using the risk-of-bias tool and SIGN-checklists. THC- and CBD-based medicines, given as adjunct to pharmaco- and psychotherapy, were associated with improvements of several symptoms of mental disorders, but not with remission. Side effects occurred, but severe adverse effects were mentioned in single cases only. In order to provide reliable treatment recommendations, more and larger RCTs with follow-up assessments, consistent outcome measures and active comparisons are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00406-019-00984-4

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Literature search of systematic reviews (SR) (#Search 1)
Fig. 1 Literature search of systematic reviews (SR) (#Search 1)CC BY · PubMed Central
Fig. 2 Updated search of systematic reviews (SR) and randomized-controlled trials (RCT) (#Search 2)
Fig. 2 Updated search of systematic reviews (SR) and randomized-controlled trials (RCT) (#Search 2)CC BY · PubMed Central
Fig. 3 De novo research of systematic reviews (SRs) and randomized-controlled trials (RCTs)
Fig. 3 De novo research of systematic reviews (SRs) and randomized-controlled trials (RCTs)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 92 references

Research works printed but not linked: 5

  1. Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, London
  2. Hoch E, Friemel C, Schneider M (2018) Cannabis: Potenzial und Risiko [Cannabis: Potential and Risks]. Springer, Heidelberg
  3. National Research C, Institute of Medicine Committee on the Prevention of Mental D, Substance Abuse Among Children Y, Young Adults: Research A, Promising I (2009) The National Academies Collection: Reports funded by National Institutes of Health. In: O’Connell ME, Boat T, Warner KE (eds) Preventing mental, emotional, and behavioral disorders among young people: progress and possibilities. National Academies Press (US)
  4. OCEBM (2011) Levels of evidence working group. The oxford levels of evidence, 2 edn. Oxford Centre for Evidence-Based Medicine, Oxford. http://www.cebm.net/index.aspx?o=5653
  5. World Health Organization (2004) ICD-10: international statistical classification of diseases and related health problems/World Health Organization. World Health Organization, Geneva

Cited by

See all 131

Metadata

Authors
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O.
Affiliations
  • LMU Klinikum (DE)
  • Martin Luther University Halle-Wittenberg (DE)
Corresponding author
Hoch, Eva
Venue
European Archives of Psychiatry and Clinical Neuroscience
Published
2019-01-31
Volume
269
Issue
1
Pages
87-105
ISSN
  • 0003-9373 (ISSN-L)
  • 0940-1334
  • 1433-8491
OpenAlex
W2912950775
Cited by
131
References
92
Citations by year
2026: 8 · 2025: 13 · 2024: 17 · 2023: 22 · 2022: 22 · 2021: 20 · 2020: 18 · 2019: 11
FWCI
2.28
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • European Archives of Psychiatry and Clinical Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • OPUS (Augsburg University) (submittedVersion, cc-by)
Funders
Bundesministerium f?r Gesundheit
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Keywords
medical cannabis, cannabis-based medicines, mental illness, schizophrenia, psychosis, post-traumatic stress disorder, social anxiety, anorexia nervosa, attention deficit hyperactivity disorder, Tourette syndrome, dementia, THC, CBD, adjunctive therapy, efficacy, safety, adverse effects
MeSH terms
Mental Disorders, Cannabidiol, Humans, Dronabinol, Cannabinoid Receptor Modulators, Medical Marijuana

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. https://app.cochat.ai/papers/10.1007/s00406-019-00984-4
The paper
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019). How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-019-00984-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.